Analyst ratings
30 analysts have weighed in: a Strong Buy consensus: 24 buy calls against 1 sell, with an average 12-month price target of $281.50.
NYSE: ABBV · Drug Manufacturers - General
Over the past week, Abbvie (ABBV) pulled in about 340 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 47% bullish across the tracked sources. Wall Street is more constructive, with 24 of 30 analysts rating ABBV a buy.
There is steady buzz around ABBV this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 80% buy share sits next to a crowd that ranges from X at 44% to News at 52%. No other tracker puts the two side by side.
30 analysts have weighed in: a Strong Buy consensus: 24 buy calls against 1 sell, with an average 12-month price target of $281.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 33 points above the crowd average of 47%, the professionals are more constructive than retail. The split is inside the crowd: News reads 52% bullish while X sits at 44%, a 8-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Abbvie (ABBV) buzz held elevated around 62.3 while the price drifted up 7.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 4.5M shares. Updated Oct 10, 2026. Over the last 7 trading days, ABBV gained 6.4%. Buzz activity in the recent week averaged 57.6 and was relatively stable, swinging between 49.3 and 65.6. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 21 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ABBV and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABBV sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 11, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (24 / 5 / 1) |
| Crowd bullish (7d) | 47% |
| Avg price target | $281.50 |
| Most bullish source | News, 52% |
| Most bearish source | X, 44% |
| Sentiment spread | 8 pts |
| Mentions (7d) | 340 |
| Market cap | $481.4B |
| P/E · Forward P/E | 77.0 · 16.4 |
| EPS · Beta | $3.54 · 0.2 |
| Revenue (TTM) | $64.39B · 10% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Abbvie (ABBV) currently carries an Adanos hold signal with 77/100 conviction. The current cross-source average reads 47% bullish across 3 active sources. Those sources contribute 340 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Abbvie (ABBV) is fairly quiet with 28 mentions over the last 7 days; the 30-day context spans 17 tracked subreddits. The 7-day tone is 46% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads split on Abbvie (ABBV), averaging 47% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 52% bullish and X at 44%, a 8-point spread. On the professional side, 24 of 30 analysts rate ABBV a buy.
Of the 30 analysts covering Abbvie (ABBV), 24 rate it a buy, 5 a hold and 1 a sell, for a strong buy consensus. The average price target is $281.50. That puts the street ahead of the crowd, which averages 47% bullish.
Abbvie (ABBV)'s cross-source average is mixed at 47% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 46% bullish, News reads 52% bullish and x coverage is the most negative at 44% bullish. The combined signal points to broad mixed pressure with 77/100 conviction.
The cross-source average is mixed for Abbvie (ABBV) at 47% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is x at 44% bullish. 3-day activity momentum is falling on Reddit and X, while news activity is rising. The hold signal carries 77/100 conviction.
X is the dominant discussion channel with 200 mentions (59% of total volume). News contributes 112 mentions and Reddit contributes 28 mentions. The cross-source average is mixed at 47% bullish, while news is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABBV's hold signal at 77/100 conviction reflects a mixed cross-source average at 47% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The ABBV sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key